Latest filing published 21 Apr 2025 for Enfusion, Inc..
All filings by Neal Pawar on record concern Enfusion, Inc. Over a trading history stretching from 27 November 2023 to 21 April 2025, the count stands at 15 filings.
The open-market record consists of 5 sales worth €826k, with no purchase. Other entries cover 7 share grants. 2025 to date brings no purchases and 2 sales.
The newest entry dates from 21 April 2025: a transaction, in Enfusion, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations